Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Advanced Biomed Inc. (ADVB) vs XWELL, Inc. (XWEL)

Advanced Biomed Inc. and XWELL, Inc. are both Diagnostics & Research companies. Advanced Biomed Inc. is the larger, with a market value of $10.4M against $7.6M — 1.4× the size. XWELL, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 1.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −117.8%) and the lower return on invested capital (−29.3% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 10 and XWELL, Inc. on 2.

Valuation

Metric ADVB XWEL Diagnostics & Research median
P/E 1.35 n/m 33.95
P/S n/m 0.27 4.87
P/B 0.91 0.92 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales n/m 0.30 5.66
Earnings yield 74.15% (597.75%) (1.75%)
Free cash flow yield (35.24%) (178.41%) (0.13%)

Profitability

Metric ADVB XWEL Diagnostics & Research median
Gross margin — 34.34% 50.89%
Operating margin 0.00% (61.31%) (8.57%)
Net margin 0.00% (117.83%) (6.37%)
Free cash flow margin 0.00% (47.65%) 0.00%
Return on equity 79.17% (557.21%) (2.92%)
Return on assets 55.78% (155.10%) (6.71%)
Return on invested capital (29.27%) 0.00% 0.00%

Growth

Metric ADVB XWEL Diagnostics & Research median
Revenue growth (TTM) — (7.58%) 7.69%
EPS growth (last fiscal year) (15.01%) (38.80%) —
Revenue growth, 5-year CAGR — 28.35% 7.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.11
Current ratio 7.38 2.27 2.02
Net debt to EBITDA 1.08 (0.08) 0.78

Dividend

Metric ADVB XWEL Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio — 0.00 0.00

Size

Metric ADVB XWEL Diagnostics & Research median
Market cap 10.42m 7.64m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack